PPARS and Obesity by Gregoire, Francine M. et al.
Hindawi Publishing Corporation
PPAR Research
Volume 2007, Article ID 78475, 1 page
doi:10.1155/2007/78475
Editorial
PPARS and Obesity
Francine M. Gregoire,1 Sander Kersten,2 and Wallace Harrington3
1Department of Biology, Metabolex, Inc., 3876 Bay Center Place, Hayward, CA 94545, USA
2Division of Human Nutrition, Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The Netherlands
3Department of Metabolic Diseases, GlaxoSmithKline Research, 5 Moore Drive, Research Triangle Park, NC 27709, USA
Received 20 December 2006; Accepted 7 March 2007
Copyright © 2007 Francine M. Gregoire et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Welcome to this special issue of PPAR Research dedicated to
“PPARs and Obesity.” Obesity and the interrelated disorders
of the metabolic syndrome are a global health epidemic. To
address this major problem, it is essential to understand the
mechanisms regulating energy metabolism, and it has been
known for years that PPARs play an important role in many
facets of energy homeostasis. This is a very active and excit-
ing ﬁeld of research that, without a doubt, justiﬁes a special
issue. The genetic, molecular, and physiological aspects of
PPARs as well as the metabolic eﬀects of recently developed
PPAR and RXR agonists are among the topics discussed. The
issue begins with a review of key observations made in hu-
man subjects harboring genetic variations in PPARγ and a
thorough overview of the metabolic eﬀects of PPARs in ge-
netically modiﬁed animal models. Over the last ﬁve years,
the knowledge on PPAR delta biology has literally exploded
and the potential therapeutic usefulness of this receptor in
metabolic syndrome is now recognized. The interaction of
PPARs with uncoupling proteins regulating energy expendi-
ture is reviewed as are recent developments with RXR ag-
onists. A closely related topic addresses the molecular and
physiological functions of PPAR coactivators and corepres-
sors in relationship to adipocyte energy metabolism. The se-
lective PPAR modulator concept has attracted the attention
of the ﬁeld for over a decade; however the molecular bases
underlying their diﬀerential mode of action have only begun
to emerge recently. In addition to selective PPAR agonists,
compounds that simultaneously activate two (dual agonists)
or three (pan agonists) PPAR isoforms are in development.
The potential advantages of these new combinations are dis-
cussed. The intriguing possibility that PPARs may mediate
eﬀects of caloric restriction on longevity is also considered.
Finally, a growing body of evidence indicates that inﬂam-
mation is a key feature of the obese state and that PPARs
display strong anti-inﬂammatory properties. The evidence
that PPARs may be interesting therapeutic targets to mod-
ulate obesity-induced inﬂammation is also reviewed. While
these reviews just scratch the surface of PPAR/RXR interac-
tions and regulation of energy balance, this special issue is
packed with exciting, high quality reports from recognized
experts in the ﬁeld. We hope that the ideas presented here
will generate further interest from the scientiﬁc community
in this rapidly expanding area of research.
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